Diabetes Clinical Trials in Illinois

Showing 361-380 of 608 trials

Regulating Efficacy and Wellness in Diabetes

NCT01790724

The propose of the study is to test the hypothesis that an eight week program consisting of walking exercise and social cognitive theory based group workshops will increase physical activity adherence six months later in older adults with type 2 diabetes or metabolic syndrome.

Diabetes Type 2Metabolic Syndrome

University of Illinois at Urbana-Champaign125 participantsStarted Jan 2013

Urbana, Illinois, United States

COMPLETEDPhase 351 miles

Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus

NCT01326026

This trial is conducted in Europe and the United States of America (USA). The aim of this trial is to compare the efficacy and safety of NN1250 (insulin degludec (IDeg)) once daily in insulin naïve subjects with type 2 diabetes mellitus when titrated using two different self-titration algorithms (dose individually adjusted) in combination with metformin.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S222 participantsStarted Mar 2011

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Anaheim, California, United States +42 more locations

Regulating Efficacy and Wellness in Diabetes

Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus

Diabetes Trials in Other Cities

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial

Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes

Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent

A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin

Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen

CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride

A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650

Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes

Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes

Add Glucokinase Activator to Target A1c

A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes

Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes

Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes

Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients

Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes

Other Conditions in Illinois